'Smoker's paradox' in young patients with acute myocardial infarction

被引:36
作者
Chen, Kang-Yin [1 ,2 ]
Rha, Seung-Woon [1 ]
Li, Yong-Jian [3 ]
Jin, Zhe [3 ]
Minami, Yoshiyasu [4 ]
Park, Ji Young [1 ]
Poddar, Kanhaiya L. [1 ]
Ramasamy, Sureshkumar [1 ]
Wang, Lin [5 ]
Li, Guang-Ping [2 ]
Choi, Cheol-Ung [1 ]
Oh, Dong Joo [1 ]
Jeong, Myung Ho [3 ,6 ]
机构
[1] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea
[2] Tianjin Med Univ, Second Hosp, Dept Cardiol, Tianjin, Peoples R China
[3] Tianjin Naikai Hosp, Dept Cardiol, Tianjin, Peoples R China
[4] Shonan Kamakura Gen Hosp, Ctr Cardiovasc, Kamakura, Kanagawa, Japan
[5] Tianjin Chest Hosp, Dept Cardiol, Tianjin, Peoples R China
[6] Chonnam Natl Univ Hosp, Ctr Cardiovasc, Kwangju, South Korea
关键词
acute myocardial infarction; smoker's paradox; young patients; PERCUTANEOUS CORONARY INTERVENTION; RECEIVING THROMBOLYTIC THERAPY; CIGARETTE-SMOKING; HUMAN COSTS; TOBACCO USE; TRIAL; ANGIOPLASTY; POPULATION; RESTENOSIS; PROGNOSIS;
D O I
10.1111/j.1440-1681.2012.05721.x
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Of the patients suffering from acute myocardial infarction (AMI), smokers are younger than non-smokers, which may be a major confounding factor causing smoker's paradox. Therefore, in the present study we evaluated the smoker's paradox in young patients with AMI. In all, 1218 young AMI patients (=45years of age), comprising 990 smokers and 228 non-smokers, were enrolled in the present study. In-hospital and 8months clinical outcomes were compared between the smokers and non-smokers. Baseline clinical characteristics showed that smokers were more likely to be male (97.9% vs 72.4%; P<0.001) and had a higher rate of ST-segment elevation myocardial infarction (71.3% vs 59.5%; P=0.001) than non-smokers. Clinical outcomes showed that smokers had lower rates of in-hospital cardiac death (0.8% vs 3.5%; P=0.004), total death (0.8% vs 3.5%; P=0.004) and 8months cardiac death (1.1% vs 3.9%; P=0.006) and total death (1.3% vs 4.4%; P=0.005) than non-smokers. Multivariable logistic analysis showed that current smoking was an independent protective predictor of 8months cardiac death (odds ratio (OR) 0.25; 95% confidence interval (CI) 0.070.92; P=0.037) and total death (OR 0.26; 95% CI 0.090.82; P=0.021). Subgroup analysis in patients who underwent percutaneous coronary intervention after AMI showed that current smoking was an independent protective predictor of 8months total major adverse cardiac events (OR 0.47; 95% CI 0.230.97; P=0.041). Current smoking seems to be associated with better clinical outcomes in young patients with AMI, suggesting the existence of the smoker's paradox in this particular subset of patients.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 25 条
[1]
Andrikopoulos GK, 2002, CIRCULATION, V105, pE55
[2]
In-hospital mortality of habitual cigarette smokers after acute myocardial infarction - The 'smoker's paradox' in a countrywide study [J].
Andrikopoulos, GK ;
Richter, DJ ;
Dilaveris, PE ;
Pipilis, A ;
Zaharoulis, A ;
Gialafos, JE ;
Toutouzas, PK ;
Chimonas, ET .
EUROPEAN HEART JOURNAL, 2001, 22 (09) :776-784
[3]
[Anonymous], 1990, JAMA, V263, P3312
[4]
EVALUATION OF PARADOXIC BENEFICIAL-EFFECTS OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - MECHANISM OF THE SMOKERS PARADOX FROM THE GUSTO-I TRIAL, WITH ANGIOGRAPHIC INSIGHTS [J].
BARBASH, GI ;
REINER, J ;
WHITE, HD ;
WILCOX, RG ;
ARMSTRONG, PW ;
SADOWSKI, Z ;
MORRIS, D ;
AYLWARD, P ;
WOODLIEF, LH ;
TOPOL, EJ ;
CALIFF, RM ;
ROSS, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1222-1229
[5]
SIGNIFICANCE OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - EXPERIENCE GLEANED FROM THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL [J].
BARBASH, GI ;
WHITE, HD ;
MODAN, M ;
DIAZ, R ;
HAMPTON, JR ;
HEIKKILA, J ;
KRISTINSSON, A ;
MOULOPOULOS, S ;
ERNESTO ;
PAOLASSO ;
VANDERWERF, T ;
PEHRSSON, K ;
SANDOE, E ;
SIMES, J ;
WILCOX, RG ;
VERSTRAETE, M ;
VONDERLIPPE, G ;
VANDEWERF, F .
CIRCULATION, 1993, 87 (01) :53-58
[6]
THE HUMAN COSTS OF TOBACCO USE .1. [J].
BARTECCHI, CE ;
MACKENZIE, TD ;
SCHRIER, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) :907-912
[7]
Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease [J].
Berger, Jeffrey S. ;
Bhatt, Deepak L. ;
Steinhubl, Steven R. ;
Shao, Mingyuan ;
Steg, P. Gabriel ;
Montalescot, Gilles ;
Hacke, Werner ;
Fox, Keith A. ;
Lincoff, A. Michael ;
Topol, Eric J. ;
Berger, Peter B. .
CIRCULATION, 2009, 120 (23) :2337-2344
[8]
Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [J].
Chen, Kang-Yin ;
Rha, Seung-Woon ;
Li, Yong-Jian ;
Poddar, Kanhaiya L. ;
Jin, Zhe ;
Minami, Yoshiyasu ;
Wang, Lin ;
Kim, Eung Ju ;
Park, Chang Gyu ;
Seo, Hong Seog ;
Oh, Dong Joo ;
Jeong, Myung Ho ;
Ahn, Young Keun ;
Hong, Taek Jong ;
Kim, Young Jo ;
Hur, Seung Ho ;
Seong, In Whan ;
Chae, Jei Keon ;
Cho, Myeong Chan ;
Bae, Jang Ho ;
Choi, Dong Hoon ;
Jang, Yang Soo ;
Chae, In Ho ;
Kim, Chong Jin ;
Yoon, Jung Han ;
Chung, Wook Sung ;
Seung, Ki Bae ;
Park, Seung Jung .
CIRCULATION, 2009, 119 (25) :3207-3214
[9]
Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention - Another smoker's paradox? [J].
Cohen, DJ ;
Doucet, M ;
Cutlip, DE ;
Ho, KKL ;
Popma, JJ ;
Kuntz, RE .
CIRCULATION, 2001, 104 (07) :773-778
[10]
Interaction Between Cigarette Smoking and Clinical Benefit of Clopidogrel [J].
Desai, Nihar R. ;
Mega, Jessica L. ;
Jiang, Songtao ;
Cannon, Christopher P. ;
Sabatine, Marc S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (15) :1273-1278